Russell Sloboda serves as the Principal Toxicologist at Nelson Labs, bringing over three decades of specialized experience in toxicological risk assessment and related fields. His extensive expertise encompasses chemical exposure modeling, biocompatibility evaluations, and analytical chemistry, making him a pivotal figure in ensuring the safety...
Russell Sloboda serves as the Principal Toxicologist at Nelson Labs, bringing over three decades of specialized experience in toxicological risk assessment and related fields. His extensive expertise encompasses chemical exposure modeling, biocompatibility evaluations, and analytical chemistry, making him a pivotal figure in ensuring the safety and compliance of medical devices and drug container systems. As the lead author of more than 263 toxicological risk assessments (TRAs) and biocompatibility evaluation reports (BERs), Russell has significantly contributed to the understanding of human health risks associated with various products, including 185 medical devices.
In his current role, Russell plays a crucial part in peer reviewing and authoring TRA reports, while also providing strategic input on best practices for the implementation of the recently finalized international standard, ISO 10993-17. His involvement in project analytical study design ensures that toxicological assessments are robust and aligned with regulatory expectations. Russell’s expertise is further demonstrated through his active participation in meetings with the FDA and other regulatory bodies, where he provides critical insights that shape the landscape of toxicological safety and compliance.
With a strong foundation in environmental science and compliance, Russell is adept at navigating complex issues related to hazardous waste management and human health risk assessments. His skills in statistical analysis and QA data review enhance the reliability of the assessments he oversees, ensuring that they meet the highest standards of scientific rigor. As a thought leader in the field, Russell Sloboda continues to drive advancements in toxicological risk assessment, contributing to safer healthcare solutions and promoting environmental awareness within the industry.
